Chronic Diseases Management Market Overview:

The global chronic disease management market is estimated to expand by exhibiting a CAGR of 17.5% over the forecast period from 2017 to 2023. Chronic disease management systems are generally known and considered as primary care systems for diseases such as cancer, diabetes, asthma, stroke, and cardiovascular diseases. Additionally, the system is able to manage the visits and emergency support from healthcare providers as well as physicians, which is driving growth of the global chronic disease management market.

Get Sample Report at https://www.marketresearchfuture.com/sample_request/981

Interior rehabilitation and care centers are increasingly adopting the chronic disease management systems, which is driving growth of the market. Additionally, increasing awareness about the availability of such systems among patients suffering from chronic diseases, which is fueling growth of the market. Increasing the population having chronic diseases is encouraging the penetration of chronic disease management systems.

According to the World Health Organization (WHO), by 2020, chronic diseases are likely to account for three-quarters of deaths, especially in the developing countries. Around 71% of deaths might occur due to ischaemic heart disease (IHD) and 75% due to stroke. On a global basis, about 60% of deaths are occurred will be due to chronic diseases in developing countries. These numbers are augmenting the need for advanced healthcare and monitoring systems, which is likely to fuel the market growth in the forthcoming years. Further, factors such as increased smoking cases and stress levels in the working class are augmenting adoption of digital systems monitoring health, which is triggering growth of the global chronic disease management market.

However, the availability of expensive treatments coupled with poor reimbursement policies, especially across the developing region, is hampering growth of the market.

Competitive Analysis:

Some of the major companies in the global Chronic Disease Management Market include TriZetto Corporation, Pegasystems Inc., Phytel Inc, Wellcentive, Inc, AxisPoint Health, Medecision, Inc, HealthSmart Holdings, Inc, i2i Systems, Inc, Allscripts Healthcare Solutions, Inc., Epic Corporation Inc, ZeOmega Inc., Harmony Information Systems, Inc., and Infosys Limited.

Segmentation:

The global chronic disease management market is segmented on the basis of application, service types, deployment, end user, and region.

Based on the service type, the market is segmented into implementation service, consulting service, educational services, and others.

Based on the application, the market is segmented into cancer, asthma, cardiovascular, stroke, diabetes, and others.

Based on the deployment, the market is estimated to segment into web-based, on-premise, and cloud-based.

Based on end users, the market is segmented into payer and provider.

Regional Analysis:

Regionally, the chronic disease management market is segmented into the Americas, Asia Pacific, Europe, and the Middle East & Africa. Of these, the Americas are estimated to remain dominant in the global chronic disease management market in the coming period due to the high incidence of chronic diseases, healthcare spending, unhealthy diet, and an increase in stress level. Additionally, less need for physical exercise resulting in the highest occurrence of diseases coupled with increasing government support and investment for research & development of novel drugs and management devices to drive the market growth in the chronic disease management market in the region.

Europe is estimated to hold a second leading position in terms of revenue in the overall chronic disease management market owing to the strong presence of key players in the region and large investment for improving the disease management systems. In addition, the European market is gaining support from the several favorable policies implemented by the government for encouraging the penetration of chronic disease management systems.

However, the Asia Pacific is one of the fastest-growing regions owing to a surge in patient pool suffering from chronic diseases. Further, the increasing investment for the adoption of advanced healthcare technologies coupled with growing demand for the newer treatment and technologies are driving growth of the global chronic disease management market in China and India. Moreover, increasing demand for quality medical facilities is driving growth of the global chronic disease management market.

Get Full Report at https://www.marketresearchfuture.com/reports/chronic-disease-management-market-981

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com